NEW MJ NEWS

MariMed Announces the Filing of its final Non-Offering Prospectus

MariMed, Inc. (“MariMed” or the “Company”) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has obtained a receipt for its final non-offering, long form prospectus dated June 29, 2022 from the Ontario Securities Commission.

Concurrent with its prospectus filing, the Company also received conditional approval from the Canadian Securities Exchange (the “CSE”) to list the Company’s common shares on the CSE under the symbol “MRMD”. Listing of the common shares is subject to the satisfaction of certain customary conditions, including the receipt by the CSE of all final documentation. The Company anticipates the dual listing on the CSE to be effective in July of 2022.

“Completing the prospectus filing process is the last significant milestone necessary to fulfill the Company’s goal of attaining a dual listing on the CSE,” said Susan Villare, Chief Financial Officer of MariMed. “We believe this listing will improve liquidity enabling increased trading volume and allow for more accessible trading for some investors that currently cannot invest in MariMed.”

ABOUT MARIMED
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

For More Information, Contact:

Investor Relations:
Steve West, Vice President, Investor Relations
Email: ir@marimedinc.com

Media Contact:
Howard Schacter, Chief Communications Officer
Email: h.schacter@marimedinc.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Supreme Cannabis Company (FIRE.TO) (SPRWF) Second Quarter Earnings Release Scheduled for February 12, 2019

Supreme Cannabis Second Quarter Earnings Release Scheduled for February 12, 2019  The…

4Front Ventures Corp. (FFNTF) to Report Second Quarter 2022 Financial Results on August 15, 2022

4Front Ventures to Report Second Quarter 2022 Financial Results on August 15,…

TransCanna Holdings Inc. (TCAN) (TCAN.CN) Acquires Massive Vertically Integrated Cannabis Facility in California

TransCanna Acquires Massive Vertically Integrated Cannabis Facility in California TransCanna Holdings Inc. (CSE:…

Canopy Growth Corporation (CGC) to Expo West Bringing Lineup of CBD Products and Industry Panel to Show Attendees

Canopy Growth Heads to Expo West Bringing Lineup of CBD Products and…